SCHEMBL19638019

SCHEMBL19638019

N#Cc1sc(N)nc1-c1cccs1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.61
KMT2A Q03164 8/20 0.61
ALDH1A1 P00352 9/20 0.51
ADORA2A P29274 5/20 0.50
ADORA1 P30542 4/20 0.50
ADORA2B P29275 1/20 0.50
KDM4E B2RXH2 7/20 0.48
MAPT P10636 5/20 0.48
HSD17B10 Q99714 3/20 0.48
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C9 P11712 3/20 0.48
CYP2C19 P33261 3/20 0.48
MAPK1 P28482 2/20 0.48
GAA P10253 1/20 0.48
ALOX15 P16050 1/20 0.48
HTT P42858 1/20 0.48
HPGD P15428 3/20 0.46
POLB P06746 1/20 0.46
PIM1 P11309 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154346 0.78 MEN1 (0.71) MEN1KMT2AALDH1A1ADORA2AADORA1
SCHEMBL1449744 0.75 CDC7 (0.58) ALDH1A1ADORA2AADORA1KDM4EMAPT
SCHEMBL29518891 0.75 MEN1 (0.67) MEN1KMT2AALDH1A1ADORA2AADORA1
SCHEMBL1853759 0.73 CDC7 (0.60) MEN1KMT2AALDH1A1ADORA2AADORA1
SCHEMBL19638048 0.72 MYC (0.38) MEN1KMT2AALDH1A1ADORA2AADORA1
SCHEMBL1848871 0.71 HSD17B10 (0.64) MEN1KMT2AALDH1A1ADORA2AADORA1
SCHEMBL22331510 0.71 ADORA1 (0.51) ADORA2AADORA1
SCHEMBL19637950 0.71 TGFBR1 (0.45) ALDH1A1ADORA2AADORA1ADORA2BHSD17B10
SCHEMBL19638228 0.70 MYC (0.44) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL1850971 0.70 TGFBR1 (0.51) ALDH1A1KDM4EMAPTCYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110198939-B Modulators of adenosine A3 receptors 帕罗生物制药有限公司 2023-03-28 CN disclosed
CN-107207445-B Adenosine A3Modulators of receptors 帕罗生物制药有限公司 2021-03-16 CN disclosed
EP-3581572-B1 ADENOSINE A3 RECEPTOR MODULATORS PALOBIOFARMA SL (ES) 2020-11-25 EP disclosed
US-10744125-B2 Adenosine A3 receptor modulators PALOBIOFARMA, S.L. (ES) 2020-08-18 US disclosed
EP-3248964-B1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA SL (ES) 2019-07-17 EP disclosed
US-10238637-B2 Modulators of the adenosine A3 receptors PALOBIOFARMA, S.L. (ES) 2019-03-26 US disclosed
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS PALOBIOFARMA, S.L. (ES) 2018-09-20 US disclosed
EP-3248964-A1 THIAZOLE MODULATORS OF A3 ADENOSINE RECEPTORS PALOBIOFARMA S.L. (ES) 2017-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180263963-A1 MODULATORS OF THE ADENOSINE A3 RECEPTORS ADORA3, ADORA2A, ADORA1 MEN1 3374/4885KMT2A 4093/4885ALDH1A1 483/4885
US-10744125-B2 Adenosine A3 receptor modulators ADORA3, ADORA2A, ADORA1 MEN1 3716/4885KMT2A 3418/4885ALDH1A1 434/4885
US-10238637-B2 Modulators of the adenosine A3 receptors ADORA3, ADORA2A, ADORA1 MEN1 3374/4885KMT2A 4093/4885ALDH1A1 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.